Literature DB >> 12457383

Perinatal risk factors for schizophrenia: diagnostic specificity and relationships with maternal psychopathology.

Hélène Verdoux1, Anne-Laure Sutter.   

Abstract

Although a growing body of evidence supports the hypothesis that exposure to obstetric complications (OCs) increases the vulnerability for schizophrenia, some questions remain unanswered regarding the diagnostic specificity and the etiological significance of this association. Associations with a history of OCs have been reported for other severe psychiatric disorders, such as autism, anorexia nervosa, or psychotic affective disorder. Thus, OCs may increase in a relatively non-specific way the vulnerability for a range of severe mental disorders, the expression of this vulnerability depending on the interaction between OCs and other risk factors, such as the genetic liability for specific psychiatric disorder, or exposure to later environmental risk factors. The causal pathway between OCs, maternal psychopathology, and psychotic outcome in the offspring is not fully elucidated. The directions of the associations are often bi-directional, and the mediating variables, if any, are not clearly identified. OCs may have a direct negative impact on fetal brain development, may be on the causal pathway between prepartum maternal depression/exposure to stress and increased risk of schizophrenia, or may indirectly increase the risk of child's later psychiatric disorder by acting as risk factors for maternal postpartum depression. The links and possible interactions between somatic perinatal risk factors and maternal psychopathology in the association with offspring's increased vulnerability for psychosis have to be further explored. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12457383     DOI: 10.1002/ajmg.10906

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Perinatal complications in unaffected sisters of anorexia nervosa patients: testing a covariation model between genetic and environmental factors.

Authors:  Angela Favaro; Elena Tenconi; Romina Bosello; Daniela Degortes; Paolo Santonastaso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-12-31       Impact factor: 5.270

2.  Association of adverse prenatal exposure burden with child psychopathology in the Adolescent Brain Cognitive Development (ABCD) Study.

Authors:  Joshua L Roffman; Eren D Sipahi; Kevin F Dowling; Dylan E Hughes; Casey E Hopkinson; Hang Lee; Hamdi Eryilmaz; Lee S Cohen; Jodi Gilman; Alysa E Doyle; Erin C Dunn
Journal:  PLoS One       Date:  2021-04-28       Impact factor: 3.240

Review 3.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06

4.  Environmental influences that affect attention deficit/hyperactivity disorder: study of a genetic isolate.

Authors:  David A Pineda; Luis Guillermo Palacio; Isabel C Puerta; Vilma Merchán; Clara P Arango; Astrid Yuleth Galvis; Mónica Gómez; Daniel Camilo Aguirre; Francisco Lopera; Mauricio Arcos-Burgos
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-08       Impact factor: 4.785

5.  Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia.

Authors:  Carmit Nadri; Galila Agam
Journal:  J Mol Neurosci       Date:  2008-07-15       Impact factor: 3.444

6.  Familial liability, obstetric complications and childhood development abnormalities in early onset schizophrenia: a case control study.

Authors:  Francesco Margari; Maria G Petruzzelli; Paola A Lecce; Orlando Todarello; Andrea De Giacomo; Elisabetta Lucarelli; Domenico Martinelli; Lucia Margari
Journal:  BMC Psychiatry       Date:  2011-04-14       Impact factor: 3.630

Review 7.  Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia.

Authors:  Frédéric Limosin
Journal:  BMC Psychiatry       Date:  2014-03-26       Impact factor: 3.630

8.  Ankyrin-3 as a molecular marker of early-life stress and vulnerability to psychiatric disorders.

Authors:  A Luoni; R Massart; V Nieratschker; Z Nemoda; G Blasi; M Gilles; S H Witt; M J Suderman; S J Suomi; A Porcelli; G Rizzo; L Fazio; S Torretta; A Rampino; A Berry; P Gass; F Cirulli; M Rietschel; A Bertolino; M Deuschle; M Szyf; M A Riva
Journal:  Transl Psychiatry       Date:  2016-11-08       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.